|
Clinical study of GMCI in Pancreatic Cancer
|
5R43CA119847-02
|
$376,666
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
Processing Ac-227 sources for lead-212 and radium-223 required by cancer research
|
1R41CA124302-01A1
|
$111,300
|
Soderquist, Chuck
|
ALPHAMED, INC
|
|
RTOG Tissue Bank
|
5U24CA114734-03
|
$793,043
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Tumor Suppressor Function of Smad4 by Ubiquitin
|
5R01CA108454-04
|
$224,756
|
FENG, XIN-HUA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Regulation of p21waf1/cip1 by Rho and Ras signaling
|
5R01CA030721-05
|
$182,278
|
OLSON, MICHAEL
|
BEATSON INSTITUTE FOR CANCER RESEARCH
|
|
Ras Peptide Aptamers
|
5R01CA108795-03
|
$320,225
|
XU, C
|
BIOLOGICAL RESEARCH INSTITUTE
|
|
NADPH oxidase and pancreatic cancer cell survival
|
5R01CA119025-02
|
$72,009
|
GUKOVSKAYA, ANNA
|
BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE
|
|
Prospective Cohort Collaborative in Pancreatic Cancer Epidemiology & Pathogenesis
|
1R01CA124908-01
|
$927,630
|
FUCHS, CHARLES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Polymorphisms and Haplotypes in the IGF Pathway and Endometrial Cancer Risk
|
5R03CA121362-02
|
$84,963
|
McGrath, Monica
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Biomarkers and Therapeutic Targets in Pancreatic Cancer
|
5R01CA114103-03
|
$287,037
|
WHANG, EDWARD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mutant mouse models of exocrine pancreatic cancer
|
7R01CA101973-04
|
$209,928
|
David, Tuveson
|
CAMBRIDGE RESEARCH INSTITUTE (CRUK)
|
|
Multi-Center Study of Pancratic Cancer Etiology
|
5R01CA102765-04
|
$1,131,891
|
POTTER, JOHN
|
CENTER FOR HEALTH STUDIES
|
|
Collagen XV as a tumor and metastasis suppressor.
|
1R21CA129258-01
|
$182,539
|
HARRIS, ANN
|
CHILDREN'S MEMORIAL HOSPITAL (CHICAGO)
|
|
Transforming growth factor beta signaling pathways
|
2R01CA055536-16
|
$308,158
|
HOWE, PHILIP
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
An integrative approach to cancer gene discovery in hepatocellular carcinoma
|
1R01CA124648-01
|
$416,058
|
POWERS, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
|
CSHL CANCER CENTER SUPPORT GRANT
|
5P30CA045508-21
|
$4,086,019
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
Novel Approaches for Pancreatic Cancer Therapy
|
5R01CA098712-05
|
$344,260
|
FISHER, PAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
PTEN Tumor Suppressor and Signal Transduction
|
5R01CA082783-07
|
$241,297
|
Parsons, Ramon
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Columbia-GHI Consortium for Claims-Based Cancer Studies
|
5R21CA114064-02
|
$162,462
|
STELLMAN, STEVEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Mouse Model for Human Pancreatic Ductal Adenocarcinoma
|
5R01CA109525-04
|
$250,358
|
SU, GLORIA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Detection and Diagnosis of Pancreatic Cancer
|
5R01CA096924-03
|
$234,335
|
GOLD, DAVID
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
|
Bispecific Antibody Pretargeted Therapy of Pancreatic Cancer
|
5R01CA115755-02
|
$319,025
|
SHARKEY, ROBERT
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Genetics and Biology of Pancreatic Duct Adenocarcinoma
|
5P01CA117969-02
|
$1,770,854
|
DEPINHO, RONALD
|
DANA-FARBER CANCER INSTITUTE
|
|
Evolution of Primary and Resistant Solid Tumors
|
5U01CA084313-09
|
$925,724
|
DEPINHO, RONALD
|
DANA-FARBER CANCER INSTITUTE
|
|
STAT3 in the Pathogenesis and Treatment of Pancreatic Cancer
|
5R21CA122793-02
|
$175,140
|
FRANK, DAVID
|
DANA-FARBER CANCER INSTITUTE
|
|
DF/HCC SPORE in Gastrointestinal Cancer
|
1P50CA127003-01
|
$2,300,001
|
FUCHS, CHARLES
|
DANA-FARBER CANCER INSTITUTE
|
|
Flavopiridol Mediated Apoptosis During S Phase
|
5R01CA090687-07
|
$313,185
|
SHAPIRO, GEOFFREY
|
DANA-FARBER CANCER INSTITUTE
|
|
Adult pancreatic progenitor cells as target of early oncogenic events
|
1R21CA127095-01
|
$191,880
|
Carriere, Catherine
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
5P30CA023108-29
|
$3,012,185
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Role of Glypican-1 in Pancreatic Cancer
|
5R01CA101306-05
|
$320,862
|
KORC, MURRAY
|
DARTMOUTH COLLEGE
|
|
Role of Neuropillins in Pancreatic Cancer
|
5R01CA102687-05
|
$300,000
|
KORC, MURRAY
|
DARTMOUTH COLLEGE
|
|
Innovative Assays for Oncogenic Hedgehog Signaling
|
5R01CA113656-02
|
$268,583
|
CHEN, WEI
|
DUKE UNIVERSITY
|
|
Dynamic requirements of Ras signaling during cancer
|
1R01CA123031-01A2
|
$296,400
|
Counter, Christopher
|
DUKE UNIVERSITY
|
|
Developing inhibitors of RalA function for the treatment of pancreatic cancer
|
1R21CA126903-01
|
$155,834
|
COUNTER, CHRISTOPHER
|
DUKE UNIVERSITY
|
|
Molecular Mechanisms of Neoplastic Transformation in Human Cells
|
2R01CA094184-06A1
|
$258,320
|
Counter, Christopher
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-33S1
|
$84,062
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
5P30CA014236-33
|
$6,558,287
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
KLH-pulsed dendritic cells plus TNFerade in Pancreatic Cancer
|
7R21CA115018-02
|
$245,603
|
ZERVOS, EMMANUEL
|
EAST CAROLINA UNIVERSITY
|
|
Emory-GA Tech Nanotechnology Center for Personalized an*
|
5U54CA119338-03
|
$3,565,272
|
NIE, SHUMING
|
EMORY UNIVERSITY
|
|
IAPs As Novel Targets for Cancer Therapy
|
5R01CA095643-05
|
$239,605
|
YANG, LILY
|
EMORY UNIVERSITY
|
|
Clinical Inhibition of the Stromal Target Fibroblast Activation Protein
|
1R21CA122301-01A1
|
$136,800
|
CHENG, JONATHAN
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-45S1
|
$110,114
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-45S2
|
$116,355
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
5P30CA006927-45
|
$7,949,000
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Proteomics Biomarkers Development Laboratory
|
5U01CA084982-09
|
$572,408
|
HANASH, SAMIR
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|